Plasma thioredoxin levels in patients with unstable angina

International Journal of Cardiology

Volumn 99, Issue 2, 2005, Pages 225-231

  Hokamaki, Jun ^a   Kawano, Hiroaki ^a   Soejima, Hirofumi ^a   Miyamoto, Shinzo ^a   Kajiwara, Ichiro ^a   Kojima, Sunao ^a   Sakamoto, Tomohiro ^a   Sugiyama, Seigo ^a   Yoshimura, Michihiro ^a   Nakamura, Hajime ^b   Yodoi, Junji ^b   Ogawa, Hisao ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Anginal attacks; Myocardial ischemic activity; Oxidative stress; Thioredoxin; Unstable angina

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; NITRIC ACID DERIVATIVE; THIOREDOXIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLASSIFICATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RECURRENT DISEASE; STABLE ANGINA PECTORIS; THORAX PAIN; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 20044383740     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.01.010     Document Type: Article

References (47)

1. Bolli R. Oxygen-derived free radicals and postischemic myocardial dysfunction ("stunned myocardium"). J. Am. Coll. Cardiol. 12:1988;239-249
2. Griendling K.K., Sorescu D., Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86:2000;494-501
3. Aikawa R., Nagai T., Tanaka M., et al. Reactive oxygen species in mechanical stress-induced cardiac hypertrophy. Biochem. Biophys. Res. Commun. 289:2001;901-907
4. Aikawa R., Komuro I., Yamazaki T., et al. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J. Clin. Invest. 100:1997;1813-1821
5. Harrison D., Griendling K.K., Landmesser U., Hornig B., Drexler H. Role of oxidative stress in atherosclerosis. Am. J. Cardiol. 91:2003;7A-11A
6. Kunsch C., Medford R.M. Oxidative stress as a regulator of gene expression in the vasculature. Circ. Res. 85:1999;753-766
7. Martinet W., Knaapen M.W., De Meyer G.R., Herman A.G., Kockx M.M. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation. 106:2002;927-932
8. Ferrari R., Alfieri O., Curello S., et al. Occurrence of oxidative stress during reperfusion of the human heart. Circulation. 81:1990;201-211
9. Ceconi C., Curello S., Cargnoni A., Ferrari R., Albertini A., Visioli O. The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of N-acetyl cysteine. J. Mol. Cell. Cardiol. 20:1988;5-13
10. Aota M., Matsuda K., Isowa N., Wada H., Yodoi J., Ban T. Protection against reperfusion-induced arrhythmias by human thioredoxin. J. Cardiovasc. Pharmacol. 27:1996;727-732
11. Shimomura H., Ogawa H., Takazoe K., et al. Comparison of urinary biopyrrin levels in acute myocardial infarction (after reperfusion therapy) versus stable angina pectoris and their usefulness in predicting subsequent cardiac events. Am. J. Cardiol. 90:2002;108-111
12. Nakamura H., Matsuda M., Furuke K., et al. Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. Immunol. Lett. 42:1994;75-80
13. Ohira A., Honda O., Gauntt C.D., et al. Oxidative stress induces adult T cell leukemia derived factor/thioredoxin in the rat retina. Lab. Invest. 70:1994;279-285
14. Yodoi J., Takatsuki K., Masuda T. Two cases of T-cell chronic lymphocytic leukemia in Japan [Letter]. N. Engl. J. Med. 290:1974;572-573
15. Yoshida M., Miyoshi I., Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. U. S. A. 79:1982;2031-2035
16. Teshigawara K., Maeda M., Nishino K., et al. Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression. J. Mol. Cell. Immunol. 2:1985;17-26
17. Tagaya Y., Maeda Y., Mitsui A., et al. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J. 13:1994;2244
18. Gasdaska P.Y., Oblong J.E., Cotgreave I.A., Powis G. The predicted amino acid sequence of human thioredoxin is identical to that of the autocrine growth factor human adult T-cell derived factor (ADF): thioredoxin mRNA is elevated in some human tumors. Biochim. Biophys. Acta. 1218:1994;292-296
19. Nakamura H., Nakamura K., Yodoi J. Redox regulation of cellular activation. Annu. Rev. Immunol. 15:1997;351-369
20. Nakamura H., De Rosa S., Roederer M., et al. Elevation of plasma thioredoxin levels in HIV-infected individuals. Int. Immunol. 8:1996;603-611
21. Nakamura H., Vaage J., Valen G., Padilla C.A., Bjornstedt M., Holmgren A. Measurements of plasma glutaredoxin and thioredoxin in healthy volunteers and during open-heart surgery. Free Radic. Biol. Med. 24:1998;1176-1186
22. Dhalla N.S., Golfman L., Takeda S., Takeda N., Nagano M. Evidence for the role of oxidative stress in acute ischemic heart disease: a brief review. Can. J. Cardiol. 15:1999;587-593
23. Ferrari R., Agnoletti L., Comini L., et al. Oxidative stress during myocardial ischaemia and heart failure. Eur. Heart J. 19:1998;B2-B11
24. Hogg N. Free radicals in disease. Semin. Reprod. Endocrinol. 16:1998;241-248
25. Kishimoto C., Shioji K., Nakamura H., Nakayama Y., Yodoi J., Sasayama S. Serum thioredoxin (TRX) levels in patients with heart failure. Jpn. Circ. J. 65:2001;491-494
26. Miwa K., Kishimoto C., Nakamura H., et al. Increased oxidative stress with elevated serum thioredoxin level in patients with coronary spastic angina. Clin. Cardiol. 26:2003;177-181
27. Miyamoto S., Sakamoto T., Soejima H., et al. Plasma thioredoxin levels and platelet aggregability in patients with acute myocardial infarction. Am. Heart J. 146:2003;465-471
28. Hirai N., Kawano H., Yasue H., et al. Attenuation of nitrate tolerance and oxidative stress by an angiotensin II receptor blocker in patients with coronary spastic angina. Circulation. 108:2003;1446-1450
29. Kugiyama K., Ota Y., Sugiyama S., et al. Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectoris. Am. J. Cardiol. 86:2000;718-722
30. Braunwald E. Unstable angina. A classification. Circulation. 80:1989;410-414
31. Yasue H., Horio Y., Nakamura N., et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation. 74:1986;955-963
32. Kawano H., Yasue H., Hirai N., et al. Effects of transdermal and oral estrogen supplementation on endothelial function, inflammation and cellular redox state. Int. J. Clin. Pharmacol. Ther. 41:2003;346-353
33. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 20:1997;1183-1197
34. Kajiwara I., Ogawa H., Soejima H., et al. The prognostic value of small-sized platelet aggregates in unstable angina: detection by a novel laser-light scattering method. Thromb. Res. 101:2001;109-118
35. Ikeda H., Koga Y., Oda T., et al. Free oxygen radicals contribute to platelet aggregation and cyclic flow variations in stenosed and endothelium-injured canine coronary arteries. J. Am. Coll. Cardiol. 24:1994;1749-1756
36. Jourdan A., Aguejouf O., Imbault P., Doutremepuich F., Inamo J., Doutremepuich C. Experimental thrombosis model induced by free radicals. Application to aspirin and other different substances. Thromb. Res. 79:1995;109-123
37. Rajagopalan S., Meng X.P., Ramasamy S., Harrison D.G., Galis Z.S. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J. Clin. Invest. 98:1996;2572-2579
38. Inoue N., Takeshita S., Gao D., et al. Lysophosphatidylcholine increases the secretion of matrix metalloproteinase 2 through the activation of NADH/NADPH oxidase in cultured aortic endothelial cells. Atherosclerosis. 155:2001;45-52
39. Azumi H., Inoue N., Ohashi Y., et al. Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase. Arterioscler. Thromb. Vasc. Biol. 22:2002;1838-1844
40. Morita Y., Takahashi H., Kamihata H., Yamamoto Y., Hara K., Iwasaka T. Urinary excretion of biopyrrins, oxidative metabolites of bilirubin, increases after spasm provocation tests in patients with coronary spastic angina. Int. J. Cardiol. 80:2001;243-250
41. Mitsui A., Hirakawa T., Yodoi J. Reactive oxygen-reducing and protein-refolding activities of adult T cell leukemia-derived factor/human thioredoxin. Biochem. Biophys. Res. Commun. 186:1992;1220-1226
42. Das K.C., Das C.K. Thioredoxin, a singlet oxygen quencher and hydroxyl radical scavenger: redox independent functions. Biochem. Biophys. Res. Commun. 277:2000;443-447
43. Takagi Y., Mitsui A., Nishiyama A., et al. Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc. Natl. Acad. Sci. U. S. A. 96:1999;4131-4136
44. Hotta M., Tashiro F., Ikegami H., et al. Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. J. Exp. Med. 188:1998;1445-1451
45. Shioji K., Kishimoto C., Nakamura H., et al. Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity. Circulation. 106:2002;1403-1409
46. Turoczi T., Chang V.W., Engelman R.M., Maulik N., Ho Y.S., Das D.K. Thioredoxin redox signaling in the ischemic heart: an insight with transgenic mice overexpressing Trx1. J. Mol. Cell. Cardiol. 35:2003;695-704
47. Rajagopalan S., Kurz S., Munzel T., et al. Angiotensin II-mediated hypertension in type rat increases vascular superoxide production via membrane NADH and NADPH oxidase activation: contribution to alterations of vasomotor tone. J. Clin. Invest. 97:1996;1916-1923